Back to 
UBS Group AG
UBS Group AG
HEPA2 quarters
Position history for UBS Group AG's holdings in Hepion Pharmaceuticals, Inc.
UBS Group AG previously held 0 shares of HEPA (Hepion Pharmaceuticals, Inc.), worth $0 as of 2025-Q2.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
-1
Quarter-by-Quarter History
Other major holders of HEPA: HRT FINANCIAL LP, CITADEL ADVISORS LLC, XTX Topco Ltd, BlackRock, Inc., PNC FINANCIAL SERVICES GROUP, INC.